Loading...

BenevolentAI S.A.

BAI.ASEURONEXT
Healthcare
Biotechnology
0.08
0.00(0.00%)

BenevolentAI S.A. (BAI.AS) Stock Overview

Explore BenevolentAI S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.8/100

Key Financials

Market Cap11.2M
P/E Ratio-0.12
EPS (TTM)$-0.64
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$0.43
1 Year Target$0.21

BAI.AS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BenevolentAI S.A. (BAI.AS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.12 and a market capitalization of 11.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;